- About Us
- Nano-Social Network
- Nano Consulting
- My Account
January 17th, 2005
MTF and Asklepios Announce Collaboration
The Musculoskeletal Transplant Foundation (MTF), and Asklepios Biopharmaceutical Inc. (AskBio), a private development-stage biotechnology company, announced today that they have entered into a research collaboration to jointly develop and commercialize novel solutions to orthopedic tissue repair.
Through this collaboration, MTF gains access to AskBio’s extensive expertise in targeting and delivery of therapeutic genetic cargo to patients’ cells utilizing a platform technology, the Biological Nano Particle (BNPtm). AskBio’s BNPs have clinical advantages in delivering genetic therapeutic cargo to a platform of applications that MTF will apply to improve the performance of allograft in an array of orthopedic procedures.
|Related News Press|
Rare-earths become water-repellent only as they age March 22nd, 2017
Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017
Arrowhead Provides Response to New Minority Shareholder Announcement January 7th, 2017
Nanocages for gold particles: what is happening inside? March 16th, 2017
Leti Presents Advances in Propagation Modeling and Antenna Design for mmWave Spectrum: Paper Is One of 15 that Leti Presented at European Conference on Antennas and Propagation March 19-24 March 23rd, 2017